Clinical Trials Logo
  1. Home
  2. Magnesium Deficiency
  3. NCT04216836

One Week of Magnesium Supplementation Lowers IL-6, Perceived Pain and Increases Post Exercise Blood Glucose in Response to Downhill Running

Magnesium Deficiency Clinical Trial

Official title:
One Week of Magnesium Supplementation Lowers IL-6, Perceived Pain and Increases Post Exercise Blood Glucose in Response to Downhill Running

Clinical Trial Summary

This study investigated the effect of magnesium supplementation on exercise performance and functional recovery in recreational endurance athletes in conjunction with measures of blood glucose, lactate, IL-6 and sIL-6R.

Clinical Trial Description

Magnesium status can directly affect circulating glucose concentrations both during and post exercise. In addition, magnesium supplementation has been shown to reduce circulating IL-6 concentrations post exercise in humans. It is conceivable that such observations are linked through the role of IL-6 in glucose regulation, possibly in combination with sIL-6R. Together, magnesium intake may have the potential to effect exercise performance and recovery through glucose availability. This in turn may be connected to the production of IL-6 and sIL-6R which have been established to influence exercise fatigue and perception of pain (muscle soreness). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04216836
Study type Interventional
Source University of Worcester
Contact
Status Completed
Phase N/A
Start date June 28, 2018
Completion date March 1, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT04130620 - Validation of the Magnesium Muscle Stretch Test
Completed NCT01593501 - How Does Magnesium Status Influence Calcium Homeostasis? Phase 4
Recruiting NCT04942119 - Impact of Long-term Serum Magnesium and Potassium Levels Optimization and Multifactorial Adherence Intervention on the Progression of Diabetic Kidney Disease. N/A
Recruiting NCT05149820 - Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments Phase 4
Completed NCT02032186 - A Randomized Clinical Trial of Oral Magnesium Supplementation in Pregnancy Phase 3
Completed NCT03353636 - Bioavailability of Magnesium Supplements N/A
Completed NCT04972344 - Preoperative Ionized Magnesium Assessment
Completed NCT02719925 - Mineral Water Rich in Magnesium and Perceived Stress in Healthy Consumers N/A
Completed NCT05630339 - Magnesium and Vitamin D Combination for Post-COVID Syndrome N/A
Completed NCT03554668 - Systemic Inflammatory Response: Thiamine and Magnesium Status (Sir TaM Study)
Recruiting NCT05271838 - Protein and Magnesium in Ulcerative Colitis N/A
Completed NCT03134417 - Magnesium and Vitamin D Supplementation and Cardiometabolic Outcomes N/A
Active, not recruiting NCT02674789 - Ionized Magnesium in Athletes N/A
Completed NCT03466528 - Alcohol: Thiamine and or Magnesium 1 Phase 2/Phase 3
Recruiting NCT03840226 - The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients Phase 3
Terminated NCT03471481 - Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy